Triflusal

Triflusal

CAT N°: 30274
Price:

92.00 78.20

Triflusal is an inhibitor of platelet aggregation (IC50s = 48.3 and 693 µM in isolated human whole blood and platelet-rich plasma, respectively).{52661} It inhibits production of thromboxane B2 (TXB2; Item No. 19030) and 6 keto prostaglandin F1? (6-keto-PGF1?; Item No. 15210) induced by arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) with IC50 values of 468 and 339 µM, respectively, in isolated human whole blood. Triflusal decreases IgG-ovalbumin immune complex-induced NF-?B nuclear translocation and production of nitric oxide (NO) in isolated rat peritoneal macrophages when used at a concentration of 1,000 µM.{8312} Oral administration of triflusal (30 mg/kg) reduces infarct volume and peri-infarct levels of OX-6, a marker of activated microglia, in a rat model of focal ischemia induced by permanent middle cerebral artery occlusion (MCAO).{52662} It also reduces increases in cortical amyloid-? precursor protein (APP) levels induced by intracerebroventricular administration of amyloid-? (25-35) in rats at the same dose.{52663}

We also advise you